Antibiotics Producer Warns ‘Buy European’ Rules Could Create Quasi-Monopoly
Dutch antibiotics producer Centrient is warning that a careless implementation of the “Buy European” criteria in the EU’s recently agreed Critical Medicines Act (CMA) could decrease competition in the antibiotics market, especially for...






